How drug-drug interactions can impact managed care

被引：0
|
作者：
Preskorn, SH [1 ]
机构：
[1] Univ Kansas, Dept Psychiat & Behav Sci, Lawrence, KS 66045 USA
[2] Inst Psychiat Res, Wichita, KS USA
来源：
AMERICAN JOURNAL OF MANAGED CARE | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：S186 / S198
页数：13
相关论文
共 50 条
  • [21] Evaluation of potential drug-drug interactions in intensive care unit
    Dagdelen, M. S.
    Gulen, D.
    Ceylan, I
    Girgin, N. K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (18) : 5801 - 5806
  • [22] SIGNIFICANCE OF DRUG-DRUG INTERACTIONS IN CARDIAC INTENSIVE CARE UNITS
    Havrilla-Smithburger, Pamela
    Kane-Gill, Sandra
    Benedict, Neal
    Falcione, Bonnie
    Scybert, Amy
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A460 - A460
  • [23] porPrevalence and classification of drug-drug interactions in intensive care patients
    de Almeida, Silvana Maria
    Gama, Cinthia Scatena
    Akamine, Nelson
    EINSTEIN-SAO PAULO, 2007, 5 (04): : 347 - 351
  • [24] Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
    Buchtova, Tereza
    Lukac, David
    Skrott, Zdenek
    Chroma, Katarina
    Bartek, Jiri
    Mistrik, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [25] Drug-drug interactions of antifungal agents and implications for patient care
    Gubbins, PO
    Amsden, JR
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (13) : 2231 - 2243
  • [26] Frequency and nature of drug-drug interactions in the intensive care unit
    Askari, Marjan
    Eslami, Saied
    Louws, Mathijs
    Wierenga, Peter C.
    Dongelmans, Dave A.
    Kuiper, Rob A.
    Abu-Hanna, Ameen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (04) : 430 - 437
  • [27] QT prolongation in the intensive care unit: commonly used medications and the impact of drug-drug interactions
    Smithburger, Pamela L.
    Seybert, Amy L.
    Armahizer, Michael J.
    Kane-Gill, Sandra L.
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (05) : 699 - 712
  • [28] The impact of drug-drug interactions on pulmonary arterial hypertension therapy
    Ciraci, Rocco
    Tirone, Giampaolo
    Scaglione, Francesco
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 28 (01) : 1 - 8
  • [29] Impact of drug-drug interactions on phenobarbital pharmacokinetics in pediatric patients
    Sima, Martin
    Slanar, Ondrej
    EPILEPSIA, 2019, 60 (06) : 1266 - 1267
  • [30] Clinical impact of drug-drug interactions with systemic azole antifungals
    Bates, DW
    Yu, DT
    DRUGS OF TODAY, 2003, 39 (10): : 801 - 813
12345